CompletedNot Applicable

3D Visualization System for Vitreoretinal Diseases in Highly Myopic Eyes

Taiwan40 participantsStarted 2022-10-07

Plain-language summary

To investigate the surgical outcomes and intraoperative parameters evaluation of 3D visualization system for vitreoretinal diseases in highly myopic eyes

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Highly myopic patients (axial length ≥ 26mm, no upper limit)
✓. Patient with vitreoretinal pathology that require vitrectomy who had not received previous ICG or BBG-assisted membrane peeling
✓. Patient aged ≥ 20 years

Exclusion criteria

✕. Patient who had previous ICG or BBG-assisted membrane peeling
✕. Patient who received combined vitrectomy and trabeculectomy
✕. Patient with endophthalmitis or intraocular foreign body

What they're measuring

Number of injections of ICG

Timeframe: operation day

Trial details

NCT IDNCT05367193

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-16

View on ClinicalTrials.gov More Patients With Highly Myopic Eyes trials